(Q41338181)

29 September 2017

Population pharmacokinetics of S-ketamine and norketamine in healthy volunteers after intravenous and oral dosing (English)

1 reference

29 September 2017

1 reference

4

1 reference

29 September 2017

Janne T Backman

3

0 references

author name string

Samuel Fanta

series ordinal

1

1 reference

PubMed ID

25724645

29 September 2017

Mari Kinnunen

series ordinal

2

1 reference

29 September 2017

1 March 2015

1 reference

European Journal of Clinical Pharmacology

29 September 2017

1 reference

29 September 2017

71

1 reference

29 September 2017

4

1 reference

29 September 2017

441-447

1 reference

https://scigraph.springernature.com/pub.10.1007/s00228-015-1826-y

29 September 2017

0 references

cites work

PHARMACOLOGIC EFFECTS OF CI-581, A NEW DISSOCIATIVE ANESTHETIC, IN MAN.

1 reference

https://api.crossref.org/works/10.1007%2FS00228-015-1826-Y

Pharmacokinetics and pharmacodynamics of ketamine enantiomers in surgical patients using a stereoselective analytical method.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-015-1826-Y

Effect of racemic mixture and the (S+)-isomer of ketamine on temporal and spatial summation of pain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-015-1826-Y

Peri-operative ketamine for acute post-operative pain: a quantitative and qualitative systematic review (Cochrane review).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-015-1826-Y

Population pharmacokinetic-pharmacodynamic modeling of ketamine-induced pain relief of chronic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-015-1826-Y

Ketamine for treatment-resistant unipolar depression: current evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-015-1826-Y

Simultaneous population pharmacokinetic modelling of ketamine and three major metabolites in patients with treatment-resistant bipolar depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-015-1826-Y

The role of ketamine in pain management.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-015-1826-Y

Use of oral ketamine in chronic pain management: a review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-015-1826-Y

Ketamine as adjuvant analgesic to opioids: a quantitative and qualitative systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-015-1826-Y

Ketamine spares morphine consumption after transthoracic lung and heart surgery without adverse hemodynamic effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-015-1826-Y

Metabolism of ketamine stereoisomers by human liver microsomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-015-1826-Y

Pharmacokinetics and analgesic effects of i.m. and oral ketamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-015-1826-Y

Bioavailability, pharmacokinetics, and analgesic activity of ketamine in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-015-1826-Y

Plasma concentration profiles of ketamine and norketamine after administration of various ketamine preparations to healthy Japanese volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-015-1826-Y

Development of a sublingual/oral formulation of ketamine for use in neuropathic pain: Preliminary findings from a three-way randomized, crossover study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-015-1826-Y

Rifampicin has a profound effect on the pharmacokinetics of oral S-ketamine and less on intravenous S-ketamine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-015-1826-Y

Contribution of CYP3A4, CYP2B6, and CYP2C9 isoforms to N-demethylation of ketamine in human liver microsomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-015-1826-Y

Comparative pharmacology in the rat of ketamine and its two principal metabolites, norketamine and (Z)-6-hydroxynorketamine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-015-1826-Y

S(+)-ketamine effect on experimental pain and cardiac output: a population pharmacokinetic-pharmacodynamic modeling study in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-015-1826-Y

Pharmacokinetics and non-analgesic effects of S- and R-ketamines in healthy volunteers with normal and reduced metabolic capacity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-015-1826-Y

Comparative pharmacology of the ketamine isomers. Studies in volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-015-1826-Y

Pharmacokinetics of S(+) ketamine derived from target controlled infusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-015-1826-Y

Stereoselective pharmacokinetics of ketamine: R(-)-ketamine inhibits the elimination of S(+)-ketamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-015-1826-Y

Hepatic clearance of drugs. I. Theoretical considerations of a "well-stirred" model and a "parallel tube" model. Influence of hepatic blood flow, plasma and blood cell binding, and the hepatocellular enzymatic activity on hepatic drug clearance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-015-1826-Y

Pharmacokinetics and dosage adjustment in patients with hepatic dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-015-1826-Y

Exploring the pharmacokinetics of oral ketamine in children undergoing burns procedures

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-015-1826-Y

Ketamine for perioperative pain management

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-015-1826-Y

Ketamine for depression: where do we go from here?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-015-1826-Y

Interaction of Ketamine and Halothane in Rats

21 January 2018

1 reference

12 December 2020

Ketamine as an adjuvant to opioids for cancer pain

1 reference

12 December 2020

Perioperative ketamine for acute postoperative pain

1 reference

12 December 2020

Involvement of CYP2B6 in n-demethylation of ketamine in human liver microsomes.

1 reference

12 December 2020

Ketamine--its pharmacology and therapeutic uses.

1 reference

12 December 2020

Intraoperative ketamine reduces perioperative opiate consumption in opiate-dependent patients with chronic back pain undergoing back surgery

1 reference

12 December 2020

Effects of ketamine on sensory perception: evidence for a role of N-methyl-D-aspartate receptors

1 reference

12 December 2020

10.1007/S00228-015-1826-Y

Identifiers

DOI

1 reference

release_v2k2u7gw6jgcnhv5ihxciqchny

29 September 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/v2k2u7gw6jgcnhv5ihxciqchny

24 November 2022

mapped directly with Wikidata item

PubMed ID

25724645

1 reference

PubMed ID

25724645